Skip to main content
Erschienen in: NeuroMolecular Medicine 2/2008

01.06.2008 | Original Paper

Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis

verfasst von: Mary E. McCrate, Brian K. Kaspar

Erschienen in: NeuroMolecular Medicine | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Physical exercise exerts a wide range of benefits on an organism’s overall health and well-being. Exercise contributes positively toward an individual’s healthy weight, muscle strength, immune system, and cardiovascular health. Indeed, exercise has been demonstrated to reduce life-threatening conditions such as high blood pressure, heart disease, obesity, and diabetes. Of particular interest to this review, exercise has also been shown to be neuroprotective in both the central and peripheral nervous systems. Naturally, such findings apply broadly to the study of neurodegenerative disease with numerous reports demonstrating that exercise has beneficial effects on disease progression. One of the most devastating neurodegenerative diseases is amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease in the United States, or motor neuron disease in the United Kingdom, resulting from the progressive loss of brain and spinal cord motor neurons. Several human studies show that moderate exercise regimens improve ALS patients’ scoring on functionality tests and ameliorate disease symptoms. Other promising recent works using transgenic mouse models of familial ALS have shown markedly slowed disease progression, improved function, and extension of survival in moderately exercised animals. Possible explanations for these findings include the exercise-induced changes in motor neuron morphology, muscle-nerve interaction, glial activation, and altering levels of gene expression of anti-apoptotic proteins and neurotrophic factors in the active tissue. Here we review the current literature on exercise and motor neuron disease, focusing on rodent and human studies to define the proper type, intensity, and duration of exercise necessary to enhance neuron survival as well discuss current mechanistic studies to further define the exercise-mediated pathways of neuroprotection.
Literatur
Zurück zum Zitat Abbott, N. J., Ronnback, L., & Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience, 7, 41–53.PubMedCrossRef Abbott, N. J., Ronnback, L., & Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews Neuroscience, 7, 41–53.PubMedCrossRef
Zurück zum Zitat Agre, J. C., Rodriquez, A. A., & Franke, T. M. (1997). Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Archive of Physics Medical Rehabilitation, 78, 681–686.CrossRef Agre, J. C., Rodriquez, A. A., & Franke, T. M. (1997). Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Archive of Physics Medical Rehabilitation, 78, 681–686.CrossRef
Zurück zum Zitat ALS CNS Treatment Group. (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology, 46, 1244–1249. ALS CNS Treatment Group. (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology, 46, 1244–1249.
Zurück zum Zitat Armon, C. (2007). Sports and trauma in amyotrophic lateral sclerosis revisited. Journal of the Neurological Sciences, 262, 45–53.PubMedCrossRef Armon, C. (2007). Sports and trauma in amyotrophic lateral sclerosis revisited. Journal of the Neurological Sciences, 262, 45–53.PubMedCrossRef
Zurück zum Zitat Azzouz, M., Ralph, G. S., Storkebaum, E., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429, 413–417.PubMedCrossRef Azzouz, M., Ralph, G. S., Storkebaum, E., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature, 429, 413–417.PubMedCrossRef
Zurück zum Zitat BDNF Study Group (1999). A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology, 52, 1427–1433. BDNF Study Group (1999). A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III). Neurology, 52, 1427–1433.
Zurück zum Zitat Bello-Haas, V. D., Florence, J. M., Kloos, A. D., et al. (2007). A randomized controlled trial of resistance exercise in individuals with ALS. Neurology, 68, 2003–2007.PubMedCrossRef Bello-Haas, V. D., Florence, J. M., Kloos, A. D., et al. (2007). A randomized controlled trial of resistance exercise in individuals with ALS. Neurology, 68, 2003–2007.PubMedCrossRef
Zurück zum Zitat Boillee, S., Vande Velde, C., & Cleveland, D. W. (2006a). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39–59.PubMedCrossRef Boillee, S., Vande Velde, C., & Cleveland, D. W. (2006a). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39–59.PubMedCrossRef
Zurück zum Zitat Boillee, S., Yamanaka, K., Lobsiger, C. S., et al. (2006b). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389–1392.PubMedCrossRef Boillee, S., Yamanaka, K., Lobsiger, C. S., et al. (2006b). Onset and progression in inherited ALS determined by motor neurons and microglia. Science, 312, 1389–1392.PubMedCrossRef
Zurück zum Zitat Bruijn, L. I., Becher, M. W., Lee, M. K., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–338.PubMedCrossRef Bruijn, L. I., Becher, M. W., Lee, M. K., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron, 18, 327–338.PubMedCrossRef
Zurück zum Zitat Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723–749.PubMedCrossRef Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience, 27, 723–749.PubMedCrossRef
Zurück zum Zitat Carro, E., Nunez, A., Busiguina, S., & Torres-Aleman, I. (2000). Circulating insulin-like growth factor I mediates effects of exercise on the brain. Journal of Neurosciences, 20, 2926–2933. Carro, E., Nunez, A., Busiguina, S., & Torres-Aleman, I. (2000). Circulating insulin-like growth factor I mediates effects of exercise on the brain. Journal of Neurosciences, 20, 2926–2933.
Zurück zum Zitat Carro, E., Trejo, J. L., Busiguina, S., & Torres-Aleman, I. (2001). Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. Journal of Neurosciences, 21, 5678–5684. Carro, E., Trejo, J. L., Busiguina, S., & Torres-Aleman, I. (2001). Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. Journal of Neurosciences, 21, 5678–5684.
Zurück zum Zitat Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002). Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nature Medicine, 8, 1390–1397.PubMedCrossRef Carro, E., Trejo, J. L., Gomez-Isla, T., LeRoith, D., & Torres-Aleman, I. (2002). Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nature Medicine, 8, 1390–1397.PubMedCrossRef
Zurück zum Zitat Carro, E., Trejo, J. L., Nunez, A., & Torres-Aleman, I. (2003). Brain repair and neuroprotection by serum insulin-like growth factor I. Molecular Neurobiology, 27, 153–162.PubMedCrossRef Carro, E., Trejo, J. L., Nunez, A., & Torres-Aleman, I. (2003). Brain repair and neuroprotection by serum insulin-like growth factor I. Molecular Neurobiology, 27, 153–162.PubMedCrossRef
Zurück zum Zitat Chan, K. M., Amirjani, N., Sumrain, M., Clarke, A., & Strohschein, F. J. (2003). Randomized controlled trial of strength training in post-polio patients. Muscle Nerve, 27, 332–338.PubMedCrossRef Chan, K. M., Amirjani, N., Sumrain, M., Clarke, A., & Strohschein, F. J. (2003). Randomized controlled trial of strength training in post-polio patients. Muscle Nerve, 27, 332–338.PubMedCrossRef
Zurück zum Zitat Chio, A., Benzi, G., Dossena, M., Mutani, R., & Mora, G. (2005). Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 128, 472–476.PubMedCrossRef Chio, A., Benzi, G., Dossena, M., Mutani, R., & Mora, G. (2005). Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 128, 472–476.PubMedCrossRef
Zurück zum Zitat Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2, 806–819.PubMedCrossRef Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2, 806–819.PubMedCrossRef
Zurück zum Zitat Cotman, C. W., & Berchtold, N. C. (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neuroscience, 25, 295–301.CrossRef Cotman, C. W., & Berchtold, N. C. (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neuroscience, 25, 295–301.CrossRef
Zurück zum Zitat Cudkowicz, M. E., McKenna-Yasek, D., Sapp, P. E., et al. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Annual of Neurology, 41, 210–221.CrossRef Cudkowicz, M. E., McKenna-Yasek, D., Sapp, P. E., et al. (1997). Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Annual of Neurology, 41, 210–221.CrossRef
Zurück zum Zitat Ding, Y. H., Luan, X. D., Li, J., et al. (2004). Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Current Neurovascular Research, 1, 411–420.PubMedCrossRef Ding, Y. H., Luan, X. D., Li, J., et al. (2004). Exercise-induced overexpression of angiogenic factors and reduction of ischemia/reperfusion injury in stroke. Current Neurovascular Research, 1, 411–420.PubMedCrossRef
Zurück zum Zitat Dobrowolny, G., Giacinti, C., Pelosi, L., et al. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. The Journal of Cell Biology, 168, 193–199.PubMedCrossRef Dobrowolny, G., Giacinti, C., Pelosi, L., et al. (2005). Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. The Journal of Cell Biology, 168, 193–199.PubMedCrossRef
Zurück zum Zitat Drory, V. E., Goltsman, E., Reznik, J. G., Mosek, A., & Korczyn, A. D. (2001). The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191, 133–137.PubMedCrossRef Drory, V. E., Goltsman, E., Reznik, J. G., Mosek, A., & Korczyn, A. D. (2001). The value of muscle exercise in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 191, 133–137.PubMedCrossRef
Zurück zum Zitat Dupuis, L., Oudart, H., Rene, F., Gonzalez de Aguilar, J. L., & Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101, 11159–11164.PubMedCrossRef Dupuis, L., Oudart, H., Rene, F., Gonzalez de Aguilar, J. L., & Loeffler, J. P. (2004). Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proceedings of the National Academy of Sciences of the United States of America, 101, 11159–11164.PubMedCrossRef
Zurück zum Zitat Durham, H. D., Roy, J., Dong, L., & Figlewicz, D. A. (1997). Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. Journal of Neuropathology and Experimental Neurology, 56, 523–530.PubMedCrossRef Durham, H. D., Roy, J., Dong, L., & Figlewicz, D. A. (1997). Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS. Journal of Neuropathology and Experimental Neurology, 56, 523–530.PubMedCrossRef
Zurück zum Zitat Eisen, A., Schulzer, M., MacNeil, M., Pant, B., & Mak, E. (1993). Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve, 16, 27–32.PubMedCrossRef Eisen, A., Schulzer, M., MacNeil, M., Pant, B., & Mak, E. (1993). Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve, 16, 27–32.PubMedCrossRef
Zurück zum Zitat Engesser-Cesar, C., Anderson, A. J., Basso, D. M., Edgerton, V. R., & Cotman, C. W. (2005). Voluntary wheel running improves recovery from a moderate spinal cord injury. Journal of Neurotrauma, 22, 157–171.PubMedCrossRef Engesser-Cesar, C., Anderson, A. J., Basso, D. M., Edgerton, V. R., & Cotman, C. W. (2005). Voluntary wheel running improves recovery from a moderate spinal cord injury. Journal of Neurotrauma, 22, 157–171.PubMedCrossRef
Zurück zum Zitat Engesser-Cesar, C., Ichiyama, R. M., Nefas, A. L., et al. (2007). Wheel running following spinal cord injury improves locomotor recovery and stimulates serotonergic fiber growth. European Journal of Neuroscience, 25, 1931–1939.PubMedCrossRef Engesser-Cesar, C., Ichiyama, R. M., Nefas, A. L., et al. (2007). Wheel running following spinal cord injury improves locomotor recovery and stimulates serotonergic fiber growth. European Journal of Neuroscience, 25, 1931–1939.PubMedCrossRef
Zurück zum Zitat Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007). Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Research, 1157, 126–137.PubMedCrossRef Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007). Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Research, 1157, 126–137.PubMedCrossRef
Zurück zum Zitat Gardiner, P., Dai, Y., & Heckman, C. J. (2006). Effects of exercise training on alpha-motoneurons. Journal of Applied Physiology, 101, 1228–1236.PubMedCrossRef Gardiner, P., Dai, Y., & Heckman, C. J. (2006). Effects of exercise training on alpha-motoneurons. Journal of Applied Physiology, 101, 1228–1236.PubMedCrossRef
Zurück zum Zitat Grondard, C., Biondi, O., Armand, A. S., et al. (2005). Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. Journal of Neuroscience, 25, 7615–7622.PubMedCrossRef Grondard, C., Biondi, O., Armand, A. S., et al. (2005). Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. Journal of Neuroscience, 25, 7615–7622.PubMedCrossRef
Zurück zum Zitat Gruzman, A., Wood, W. L., Alpert, E., et al. (2007). Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 104, 12524–12529.PubMedCrossRef Gruzman, A., Wood, W. L., Alpert, E., et al. (2007). Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 104, 12524–12529.PubMedCrossRef
Zurück zum Zitat Gubbay, S. S., Kahana, E., Zilber, N., Cooper, G., Pintov, S., & Leibowitz, Y. (1985). Amyotrophic lateral sclerosis. A study of its presentation and prognosis. Journal of Neurology, 232, 295–300.PubMedCrossRef Gubbay, S. S., Kahana, E., Zilber, N., Cooper, G., Pintov, S., & Leibowitz, Y. (1985). Amyotrophic lateral sclerosis. A study of its presentation and prognosis. Journal of Neurology, 232, 295–300.PubMedCrossRef
Zurück zum Zitat Gurney, M. E., Pu, H., Chiu, A. Y., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772–1775.PubMedCrossRef Gurney, M. E., Pu, H., Chiu, A. Y., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772–1775.PubMedCrossRef
Zurück zum Zitat Hamadeh, M. J., Rodriguez, M. C., Kaczor, J. J., & Tarnopolsky, M. A. (2005). Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve, 31, 214–220.PubMedCrossRef Hamadeh, M. J., Rodriguez, M. C., Kaczor, J. J., & Tarnopolsky, M. A. (2005). Caloric restriction transiently improves motor performance but hastens clinical onset of disease in the Cu/Zn-superoxide dismutase mutant G93A mouse. Muscle Nerve, 31, 214–220.PubMedCrossRef
Zurück zum Zitat Horton, W. A., Eldridge, R., & Brody, J. A. (1976). Familial motor neuron disease. Evidence for at least three different types. Neurology, 26, 460–465.PubMed Horton, W. A., Eldridge, R., & Brody, J. A. (1976). Familial motor neuron disease. Evidence for at least three different types. Neurology, 26, 460–465.PubMed
Zurück zum Zitat Hutchinson, K. J., Gomez-Pinilla, F., Crowe, M. J., Ying, Z., & Basso, D. M. (2004). Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain, 127, 1403–1414.PubMedCrossRef Hutchinson, K. J., Gomez-Pinilla, F., Crowe, M. J., Ying, Z., & Basso, D. M. (2004). Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats. Brain, 127, 1403–1414.PubMedCrossRef
Zurück zum Zitat Ischiropoulos, H., Zhu, L., Chen, J., et al. (1992). Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Archives of Biochemistry and Biophysics, 298, 431–437.PubMedCrossRef Ischiropoulos, H., Zhu, L., Chen, J., et al. (1992). Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Archives of Biochemistry and Biophysics, 298, 431–437.PubMedCrossRef
Zurück zum Zitat Jablecki, C. K., Berry, C., & Leach, J. (1989). Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve, 12, 833–841.PubMedCrossRef Jablecki, C. K., Berry, C., & Leach, J. (1989). Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve, 12, 833–841.PubMedCrossRef
Zurück zum Zitat Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1987). Fast axonal transport of acetylcholinesterase in rat sciatic motoneurons is enhanced following prolonged daily running, but not following swimming. Neuroscience Letters, 78, 156–160.PubMedCrossRef Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1987). Fast axonal transport of acetylcholinesterase in rat sciatic motoneurons is enhanced following prolonged daily running, but not following swimming. Neuroscience Letters, 78, 156–160.PubMedCrossRef
Zurück zum Zitat Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1988). Fast axonal transport of labeled proteins in motoneurons of exercise-trained rats. American Journal of Physiology, 255, C731–736.PubMed Jasmin, B. J., Lavoie, P. A., & Gardiner, P. F. (1988). Fast axonal transport of labeled proteins in motoneurons of exercise-trained rats. American Journal of Physiology, 255, C731–736.PubMed
Zurück zum Zitat Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., et al. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7, 1162–1167.PubMedCrossRef Jokic, N., Gonzalez de Aguilar, J. L., Dimou, L., et al. (2006). The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Reports, 7, 1162–1167.PubMedCrossRef
Zurück zum Zitat Julien, J. P. (2007). ALS: astrocytes move in as deadly neighbors. Nature of Neuroscience, 10, 535–537.CrossRef Julien, J. P. (2007). ALS: astrocytes move in as deadly neighbors. Nature of Neuroscience, 10, 535–537.CrossRef
Zurück zum Zitat Kaspar, B. K., Frost, L. M., Christian, L., Umapathi, P., & Gage, F. H. (2005). Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology, 57, 649–655.PubMedCrossRef Kaspar, B. K., Frost, L. M., Christian, L., Umapathi, P., & Gage, F. H. (2005). Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Annals of Neurology, 57, 649–655.PubMedCrossRef
Zurück zum Zitat Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301, 839–842.PubMedCrossRef Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science, 301, 839–842.PubMedCrossRef
Zurück zum Zitat Kim, S. U., & de Vellis, J. (2005). Microglia in health and disease. Journal of Neuroscience Research, 81, 302–313.PubMedCrossRef Kim, S. U., & de Vellis, J. (2005). Microglia in health and disease. Journal of Neuroscience Research, 81, 302–313.PubMedCrossRef
Zurück zum Zitat Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2003). Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Annals of Neurology, 53, 804–807.PubMedCrossRef Kirkinezos, I. G., Hernandez, D., Bradley, W. G., & Moraes, C. T. (2003). Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Annals of Neurology, 53, 804–807.PubMedCrossRef
Zurück zum Zitat Kleim, J. A., Cooper, N. R., & VandenBerg, P. M. (2002). Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Research, 934, 1–6.PubMedCrossRef Kleim, J. A., Cooper, N. R., & VandenBerg, P. M. (2002). Exercise induces angiogenesis but does not alter movement representations within rat motor cortex. Brain Research, 934, 1–6.PubMedCrossRef
Zurück zum Zitat Kleim, J. A., Jones, T. A., & Schallert, T. (2003). Motor enrichment and the induction of plasticity before or after brain injury. Neurochemical Research, 28, 1757–1769.PubMedCrossRef Kleim, J. A., Jones, T. A., & Schallert, T. (2003). Motor enrichment and the induction of plasticity before or after brain injury. Neurochemical Research, 28, 1757–1769.PubMedCrossRef
Zurück zum Zitat Kurtzke, J. F. (1991). Risk factors in amyotrophic lateral sclerosis. Advanced Neurology, 56, 245–270. Kurtzke, J. F. (1991). Risk factors in amyotrophic lateral sclerosis. Advanced Neurology, 56, 245–270.
Zurück zum Zitat Lambrechts, D., & Carmeliet, P. (2006). VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta, 1762, 1109–1121.PubMed Lambrechts, D., & Carmeliet, P. (2006). VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochimica et Biophysica Acta, 1762, 1109–1121.PubMed
Zurück zum Zitat Lepore, A. C., Haenggeli, C., Gasmi, M., et al. (2007). Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1(G93A) model of ALS. Brain Research [epub]. Lepore, A. C., Haenggeli, C., Gasmi, M., et al. (2007). Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1(G93A) model of ALS. Brain Research [epub].
Zurück zum Zitat Li, J., Ding, Y. H., Rafols, J. A., Lai, Q., McAllister, J. P., 2nd, & Ding, Y. (2005). Increased astrocyte proliferation in rats after running exercise. Neuroscience Letters, 386, 160–164.PubMedCrossRef Li, J., Ding, Y. H., Rafols, J. A., Lai, Q., McAllister, J. P., 2nd, & Ding, Y. (2005). Increased astrocyte proliferation in rats after running exercise. Neuroscience Letters, 386, 160–164.PubMedCrossRef
Zurück zum Zitat Liebetanz, D., Hagemann, K., von Lewinski, F., Kahler, E., & Paulus, W. (2004). Extensive exercise is not harmful in amyotrophic lateral sclerosis. European Journal of Neuroscience, 20, 3115–3120.PubMedCrossRef Liebetanz, D., Hagemann, K., von Lewinski, F., Kahler, E., & Paulus, W. (2004). Extensive exercise is not harmful in amyotrophic lateral sclerosis. European Journal of Neuroscience, 20, 3115–3120.PubMedCrossRef
Zurück zum Zitat Longstreth, W. T., McGuire, V., Koepsell, T. D., Wang, Y., & van Belle, G. (1998). Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Archives of Neurology, 55, 201–206.PubMedCrossRef Longstreth, W. T., McGuire, V., Koepsell, T. D., Wang, Y., & van Belle, G. (1998). Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Archives of Neurology, 55, 201–206.PubMedCrossRef
Zurück zum Zitat Mahoney, D. J., Rodriguez, C., Devries, M., Yasuda, N., & Tarnopolsky, M. A. (2004). Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve, 29, 656–662.PubMedCrossRef Mahoney, D. J., Rodriguez, C., Devries, M., Yasuda, N., & Tarnopolsky, M. A. (2004). Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve, 29, 656–662.PubMedCrossRef
Zurück zum Zitat Mattiazzi, M., D’Aurelio, M., Gajewski, C. D., et al. (2002). Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. Journal of Biological Chemistry, 277, 29626–29633.PubMedCrossRef Mattiazzi, M., D’Aurelio, M., Gajewski, C. D., et al. (2002). Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. Journal of Biological Chemistry, 277, 29626–29633.PubMedCrossRef
Zurück zum Zitat Mattson, M. P., Cutler, R. G., & Camandola, S. (2007). Energy intake and amyotrophic lateral sclerosis. NeuroMolecular Medicine, 9, 17–20.PubMedCrossRef Mattson, M. P., Cutler, R. G., & Camandola, S. (2007). Energy intake and amyotrophic lateral sclerosis. NeuroMolecular Medicine, 9, 17–20.PubMedCrossRef
Zurück zum Zitat Miller, R. G., Petajan, J. H., Bryan, W. W., et al. (1996). A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Annals of Neurology, 39, 256–260.PubMedCrossRef Miller, R. G., Petajan, J. H., Bryan, W. W., et al. (1996). A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis. rhCNTF ALS Study Group. Annals of Neurology, 39, 256–260.PubMedCrossRef
Zurück zum Zitat Mitchell, J., Wokke, J., & Borasio, G. (2007). Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews, CD002064. Mitchell, J., Wokke, J., & Borasio, G. (2007). Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews, CD002064.
Zurück zum Zitat Mulder, D. W., Kurland, L. T., Offord, K. P., & Beard, C. M. (1986). Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology, 36, 511–517.PubMed Mulder, D. W., Kurland, L. T., Offord, K. P., & Beard, C. M. (1986). Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology, 36, 511–517.PubMed
Zurück zum Zitat Munsat, T. L., Andres, P. L., Finison, L., Conlon, T., & Thibodeau, L. (1988). The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology, 38, 409–413.PubMed Munsat, T. L., Andres, P. L., Finison, L., Conlon, T., & Thibodeau, L. (1988). The natural history of motoneuron loss in amyotrophic lateral sclerosis. Neurology, 38, 409–413.PubMed
Zurück zum Zitat Nagano, I., Ilieva, H., Shiote, M., et al. (2005). Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. Journal of the Neurological Sciences, 235, 61–68.PubMedCrossRef Nagano, I., Ilieva, H., Shiote, M., et al. (2005). Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis. Journal of the Neurological Sciences, 235, 61–68.PubMedCrossRef
Zurück zum Zitat Narai, H., Nagano, I., Ilieva, H., et al. (2005). Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. Journal of Neuroscience Research, 82, 452–457.PubMedCrossRef Narai, H., Nagano, I., Ilieva, H., et al. (2005). Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice. Journal of Neuroscience Research, 82, 452–457.PubMedCrossRef
Zurück zum Zitat Nathanson, N., & Martin, J. R. (1979). The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. American Journal of Epidemiology, 110, 672–692.PubMed Nathanson, N., & Martin, J. R. (1979). The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. American Journal of Epidemiology, 110, 672–692.PubMed
Zurück zum Zitat Pinto, A. C., Alves, M., Nogueira, A., et al. (1999). Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J. Neurological Sciences, 169, 69–75.CrossRef Pinto, A. C., Alves, M., Nogueira, A., et al. (1999). Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J. Neurological Sciences, 169, 69–75.CrossRef
Zurück zum Zitat Qureshi, M. M., Hayden, D., Urbinelli, L., et al. (2006). Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis, 7, 173–182.PubMedCrossRef Qureshi, M. M., Hayden, D., Urbinelli, L., et al. (2006). Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotrophic Lateral Sclerosis, 7, 173–182.PubMedCrossRef
Zurück zum Zitat Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 92, 689–693.PubMedCrossRef Ripps, M. E., Huntley, G. W., Hof, P. R., Morrison, J. H., & Gordon, J. W. (1995). Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 92, 689–693.PubMedCrossRef
Zurück zum Zitat Rosen, D. R., Siddique, T., Patterson, D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62.PubMedCrossRef Rosen, D. R., Siddique, T., Patterson, D., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59–62.PubMedCrossRef
Zurück zum Zitat Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002). Premorbid weight, body mass, and varsity athletics in ALS. Neurology, 59, 773–775.PubMed Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002). Premorbid weight, body mass, and varsity athletics in ALS. Neurology, 59, 773–775.PubMed
Zurück zum Zitat Storkebaum, E., Lambrechts, D., Dewerchin, M., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature of Neuroscience, 8, 85–92.CrossRef Storkebaum, E., Lambrechts, D., Dewerchin, M., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature of Neuroscience, 8, 85–92.CrossRef
Zurück zum Zitat Strickland, D., Smith, S. A., Dolliff, G., Goldman, L., & Roelofs, R. I. (1996). Physical activity, trauma, and ALS: a case-control study. Acta Neurologica Scandinavica, 94, 45–50.PubMedCrossRef Strickland, D., Smith, S. A., Dolliff, G., Goldman, L., & Roelofs, R. I. (1996). Physical activity, trauma, and ALS: a case-control study. Acta Neurologica Scandinavica, 94, 45–50.PubMedCrossRef
Zurück zum Zitat Swain, R. A., Harris, A. B., Wiener, E. C., et al. (2003). Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience, 117, 1037–1046.PubMedCrossRef Swain, R. A., Harris, A. B., Wiener, E. C., et al. (2003). Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience, 117, 1037–1046.PubMedCrossRef
Zurück zum Zitat Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature of Neuroscience, 9, 108–118.CrossRef Urushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J. P. (2006). Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nature of Neuroscience, 9, 108–118.CrossRef
Zurück zum Zitat van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000). Delaying the onset of Huntington’s in mice. Nature, 404, 721–722.PubMedCrossRef van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000). Delaying the onset of Huntington’s in mice. Nature, 404, 721–722.PubMedCrossRef
Zurück zum Zitat Veldink, J. H., Bar, P. R., Joosten, E. A., Otten, M., Wokke, J. H., & van den Berg, L. H. (2003). Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscular Disorders, 13, 737–743.PubMedCrossRef Veldink, J. H., Bar, P. R., Joosten, E. A., Otten, M., Wokke, J. H., & van den Berg, L. H. (2003). Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscular Disorders, 13, 737–743.PubMedCrossRef
Zurück zum Zitat Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Titulaer, M. J., Wokke, J. H., & van den Berg, L. H. (2005). Physical activity and the association with sporadic ALS. Neurology, 64, 241–245.PubMed Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Titulaer, M. J., Wokke, J. H., & van den Berg, L. H. (2005). Physical activity and the association with sporadic ALS. Neurology, 64, 241–245.PubMed
Zurück zum Zitat Wiedau-Pazos, M., Goto, J. J., Rabizadeh, S., et al. (1996). Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science, 271, 515–518.PubMedCrossRef Wiedau-Pazos, M., Goto, J. J., Rabizadeh, S., et al. (1996). Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science, 271, 515–518.PubMedCrossRef
Zurück zum Zitat Wood, J. D., Beaujeux, T. P., & Shaw, P. J. (2003). Protein aggregation in motor neurone disorders. Neuropathology and Applied Neurobiology, 29, 529–545.PubMedCrossRef Wood, J. D., Beaujeux, T. P., & Shaw, P. J. (2003). Protein aggregation in motor neurone disorders. Neuropathology and Applied Neurobiology, 29, 529–545.PubMedCrossRef
Zurück zum Zitat Wu, D., Yu, W., Kishikawa, H., et al. (2007). Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Annals of Neurology, 62, 609–617.PubMedCrossRef Wu, D., Yu, W., Kishikawa, H., et al. (2007). Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Annals of Neurology, 62, 609–617.PubMedCrossRef
Zurück zum Zitat Yamanaka, K., Chun, S. J., Boillee, S., et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11, 1–3.CrossRef Yamanaka, K., Chun, S. J., Boillee, S., et al. (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nature Neuroscience, 11, 1–3.CrossRef
Metadaten
Titel
Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis
verfasst von
Mary E. McCrate
Brian K. Kaspar
Publikationsdatum
01.06.2008
Verlag
Humana Press Inc
Erschienen in
NeuroMolecular Medicine / Ausgabe 2/2008
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-008-8030-5

Weitere Artikel der Ausgabe 2/2008

NeuroMolecular Medicine 2/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.